Veterinary Medicines

Clinacin 150 mg Tablets for Dogs

Authorised
  • Clindamycin hydrochloride
Download as PDF

Product identification

Medicine name:
Clinacin 150 mg Tablets for Dogs
CLINACIN 150 mg COMPRIMIDOS PARA PERROS
Active substance:
  • Clindamycin hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clindamycin hydrochloride
    162.85
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 10 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 16 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 20 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 30 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 50 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 80 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 100 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 1419 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0112/003
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Portugal
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Spanish (PDF)
Published on: 16/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."